Interactions between synthetic vanilloids and the endogenous cannabinoid system (Q40997351)

25 September 2017

Interactions between synthetic vanilloids and the endogenous cannabinoid system (English)

1 reference

25 September 2017

0 references

1

1 reference

25 September 2017

R Pertwee

7

0 references

author name string

T Bisogno

2

1 reference

25 September 2017

D Melck

3

1 reference

25 September 2017

R Ross

4

1 reference

25 September 2017

H Brockie

5

1 reference

25 September 2017

L Stevenson

6

1 reference

25 September 2017

L De Petrocellis

8

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

25 September 2017

1 reference

25 September 2017

436

1 reference

25 September 2017

449-454

1 reference

25 September 2017

3

1 reference

Neuropharmacological mechanisms of capsaicin and related substances

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

The capsaicin receptor: a heat-activated ion channel in the pain pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

A non-pungent resiniferatoxin analogue, phorbol 12-phenylacetate 13 acetate 20-homovanillate, reveals vanilloid receptor subtypes on rat trigeminal ganglion neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Pharmacological characterization of the vanilloid receptor in the rat dorsal spinal cord.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Formation and inactivation of endogenous cannabinoid anandamide in central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Functional role of high-affinity anandamide transport, as revealed by selective inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells--implications for cell proliferation and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Isolation and expression of a mouse CB1 cannabinoid receptor gene. Comparison of binding properties with those of native CB1 receptors in mouse brain and N18TG2 neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Cannabinoids reduce hyperalgesia and inflammation via interaction with peripheral CB1 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Antihyperalgesic effects of spinal cannabinoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Molecular characterization of human and mouse fatty acid amide hydrolases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

The antinociceptive effect and pharmacokinetics of olvanil following oral and subcutaneous dosing in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

The responses of rat trigeminal ganglion neurons to capsaicin and two nonpungent vanilloid receptor agonists, olvanil and glyceryl nonamide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Systemic capsaicin and olvanil reduce the acute algogenic and the late inflammatory phase following formalin injection into rodent paw

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

A spinal mechanism of action is involved in the antinociception produced by the capsaicin analogue NE 19550 (olvanil)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

Vanilloids. 1. Analogs of capsaicin with antinociceptive and antiinflammatory activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2898%2901175-2

10.1016/S0014-5793(98)01175-2

7 January 2021

Identifiers

DOI

1 reference

25 September 2017

1 reference